AB24. Current situation and evaluation of Chinese medicine anti-angiogenesis on gastric carcinoma
Abstract

AB24. Current situation and evaluation of Chinese medicine anti-angiogenesis on gastric carcinoma

Li Hou1,2, Qing Dong1,2, Yayue Zhang1,2, Shaodan Tian1,2, Lixia Lou1,2, Zhenzhen Wang1, Heng Yang3, Xiaoqing Guo1

1Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China;2Key Laboratory of Beijing (Internal Traditional Chinese Medicine), Ministry of Education, Beijing 100700, China;3Beijing University of Chinese Medicine, Beijing 100029, China;4Dongzhimen Hospital Eastern Section Affiliated to Beijing University of Chinese Medicine, China

Abstract: Currently, the morbidity and mortality of gastric cancer in China remains high. With the further research in molecular pathology of gastric cancer occurrence, development and metastasis processes, targeted therapy or chemotherapy combined with targeted therapy has gradually become the primary research direction of gastric cancer. Recent research focuses on anti-angiogenesis targeted therapy, which is one of the mechanisms of Chinese medicine treatment on gastric cancer. Meanwhile, Chinese medicine has privileges in multi-target therapy and long-term use. We summarized papers of Chinese medicine anti-angiogenesis on gastric cancer, covering the single herb, herb extracts and herbal formulae, discussed on the ideas of holistic approach and network studies of Chinese medicine anti-angiogenesis on gastric cancer.

Keywords: Gastric cancer; anti-angiogenesis; traditional Chinese medicine

Cite this abstract as: Hou L, Dong Q, Zhang YY, Tian SD, Lou LX, Wang ZZ, Yang H, Guo XQ. Current situation and evaluation of Chinese medicine anti-angiogenesis on gastric carcinoma. Transl Gastrointest Cancer 2013;2(S1):AB24. doi: 10.3978/j.issn.2224-4778.2013.s024